183 related articles for article (PubMed ID: 17210164)
1. Proteomics in clinical interventions: achievements and limitations in biomarker development.
Sinha A; Singh C; Parmar D; Singh MP
Life Sci; 2007 Mar; 80(15):1345-54. PubMed ID: 17210164
[TBL] [Abstract][Full Text] [Related]
2. Overview of molecular, cellular, and genetic neurotoxicology.
Wallace DR
Neurol Clin; 2005 May; 23(2):307-20. PubMed ID: 15757786
[TBL] [Abstract][Full Text] [Related]
3. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
Singh MP; Patel S; Dikshit M; Gupta YK
Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
[TBL] [Abstract][Full Text] [Related]
4. So, you want to look for biomarkers (introduction to the special biomarkers issue).
LaBaer J
J Proteome Res; 2005; 4(4):1053-9. PubMed ID: 16083254
[TBL] [Abstract][Full Text] [Related]
5. Molecular approaches to the identification of biomarkers of exposure and effect--report of an expert meeting organized by COST Action B15. November 28, 2003.
Gundert-Remy U; Dahl SG; Boobis A; Kremers P; Kopp-Schneider A; Oberemm A; Renwick A; Pelkonen O
Toxicol Lett; 2005 Apr; 156(2):227-40. PubMed ID: 15737486
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric disorders biomarker identification: from proteomics to systems biology.
Reckow S; Gormanns P; Holsboer F; Turck CW
Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S70-7. PubMed ID: 18756423
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
Matharoo-Ball B; Ball G; Rees R
Vaccine; 2007 Sep; 25 Suppl 2():B110-21. PubMed ID: 17916461
[TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
10. Clinical biomarkers in drug discovery and development.
Frank R; Hargreaves R
Nat Rev Drug Discov; 2003 Jul; 2(7):566-80. PubMed ID: 12838269
[TBL] [Abstract][Full Text] [Related]
11. Toxicoproteomics: new paradigms in toxicology research.
George J; Singh R; Mahmood Z; Shukla Y
Toxicol Mech Methods; 2010 Sep; 20(7):415-23. PubMed ID: 20175663
[TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for cardiovascular disease: challenges and future directions.
May A; Wang TJ
Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
[TBL] [Abstract][Full Text] [Related]
14. New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.
Meuwis MA; Fillet M; Chapelle JP; Malaise M; Louis E; Merville MP
Expert Rev Mol Diagn; 2008 May; 8(3):327-37. PubMed ID: 18598111
[TBL] [Abstract][Full Text] [Related]
15. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
[TBL] [Abstract][Full Text] [Related]
16. Toxicogenomics in biomarker discovery.
Decristofaro MF; Daniels KK
Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
19. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
Gatzidou ET; Zira AN; Theocharis SE
J Appl Toxicol; 2007; 27(4):302-9. PubMed ID: 17429800
[TBL] [Abstract][Full Text] [Related]
20. Oral cancer proteomics.
Hu S; Wong DT
Curr Opin Mol Ther; 2007 Oct; 9(5):467-76. PubMed ID: 17932810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
